Bio Impact Capital LLC Edgewise Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 1,079,316 shares of EWTX stock, worth $26.4 Million. This represents 4.31% of its overall portfolio holdings.
Number of Shares
1,079,316
Previous 917,166
17.68%
Holding current value
$26.4 Million
Previous $24.5 Million
17.72%
% of portfolio
4.31%
Previous 3.82%
Shares
6 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.4MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$368 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$218 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$151 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$147 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$123 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.55B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...